Rights and permissions
About this article
Cite this article
Infliximab, etanercept worthwhile for RA in Spain?. Pharmacoecon. Outcomes News 459, 3 (2004). https://doi.org/10.2165/00151234-200404590-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404590-00004